(Q47653862)

4 February 2018

title

Epidemiological and clinical features of idiopathic pulmonary alveolar proteinosis in Japan (English)

1 reference

4 February 2018

pulmonary alveolar proteinosis

main subject

1 reference

Yoshikazu Inoue

1

1 reference

4 February 2018

Koh Nakata

2

1 reference

4 February 2018

Toru Arai

3

1 reference

4 February 2018

Ryushi Tazawa

4

1 reference

4 February 2018

Emi Hamano

5

1 reference

4 February 2018

Toshihiro Nukiwa

6

1 reference

4 February 2018

Koichiro Kudo

7

1 reference

4 February 2018

Naoto Keicho

8

1 reference

4 February 2018

Nobuyuki Hizawa

9

1 reference

4 February 2018

Etsuro Yamaguchi

10

1 reference

4 February 2018

Ryosuke Eda

11

1 reference

4 February 2018

Kazunori Oishi

12

1 reference

4 February 2018

Yuuka Maeda

13

1 reference

4 February 2018

Yukiko Koreeda

14

1 reference

4 February 2018

Naohiko Kodo

15

1 reference

4 February 2018

Mitsunori Sakatani

16

1 reference

4 February 2018

publication date

1 January 2006

1 reference

4 February 2018

published in

Respirology

1 reference

4 February 2018

volume

11 Suppl

1 reference

4 February 2018

page(s)

S55-60

1 reference

4 February 2018

Pulmonary alveolar proteinosis: progress in the first 44 years

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2006.00810.X

Pulmonary alveolar proteinosis: clinical aspects and current concepts on pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2006.00810.X

Exogenous granulocyte-macrophage colony-stimulating factor administration for pulmonary alveolar proteinosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2006.00810.X

Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2006.00810.X

Granulocyte-macrophage colony-stimulating factor and lung immunity in pulmonary alveolar proteinosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2006.00810.X

Serum neutralizing capacity of GM-CSF reflects disease severity in a patient with pulmonary alveolar proteinosis successfully treated with inhaled GM-CSF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2006.00810.X

Relationship of anti-GM-CSF antibody concentration, surfactant protein A and B levels, and serum LDH to pulmonary parameters and response to GM-CSF therapy in patients with idiopathic alveolar proteinosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2006.00810.X

10.1111/J.1440-1843.2006.00810.X

21 January 2018

Identifiers

DOI

1 reference

4 February 2018

1 reference

4 February 2018